Literature DB >> 10027949

Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH.

J L Renaux1, M Thomas, T Crost, N Loughraieb, G Vantard.   

Abstract

BACKGROUND: The kallikrein-kinin system activation by contact with a negatively charged surface has been promulgated to be responsible for hypersensitivity reactions. However, to explain the low frequency and heterogeneity of hypersensitivity reactions, we hypothesized that not only the electronegativity of the membrane, but also other physicochemical parameters could influence the activation of the contact phase system of plasma assessed by the measurement of kallikrein activity and bradykinin concentration.
METHODS: Plasma kallikrein activity using chromogenic substrate (S2302) and plasma bradykinin concentration (enzyme immuno assay) were measured during the perfusion of human plasma (2.5 ml/min) through minidialyzers mounted with six different membranes [polyacrylonitrile (PAN) from Asahi (PANDX) and from Hospal (AN69), polymethylmethacrylate (PMMA) from Toray, cellulose triacetate (CT) from Baxter, cuprophane (CUP) from Akzo and polysulfone (PS) from Fresenius].
RESULTS: A direct relationship was shown between the electronegativity of the membrane assessed by its zeta potential and the activation of plasma during the first five minutes of plasma circulation. With the AN69 membrane, the detection of a kallikrein activity in diluted plasma but not in undiluted samples confirmed the importance of a protease-antiprotease imbalance leading to bradykinin release during the first five minutes of dialysis. With PAN membranes, the use of citrated versus heparinized plasma and the use of various rinsing solutions clearly show a dramatic effect of pH on the kallikrein activity and the bradykinin concentration measured in plasma. Finally, increasing the zeta potential of the membrane leads to a significant increase of plasma kallikrein activity and bradykinin concentration.
CONCLUSIONS: Our in vitro experimental approach evidences the importance of the control of these physicochemical factors to decrease the activation of the contact system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027949     DOI: 10.1046/j.1523-1755.1999.0550031097.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients.

Authors:  Theresa I Shireman; Jonathan D Mahnken; Milind A Phadnis; Edward F Ellerbeck; James B Wetmore
Journal:  Kidney Blood Press Res       Date:  2016-11-21       Impact factor: 2.687

2.  Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.

Authors:  Albert Adam; Nicolas Montpas; David Keire; Anik Désormeaux; Nancy J Brown; François Marceau; Benjamin Westenberger
Journal:  Biomaterials       Date:  2010-04-27       Impact factor: 12.479

3.  Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.

Authors:  Jorge L Gamboa; Mias Pretorius; Deanna R Todd-Tzanetos; James M Luther; Chang Yu; T Alp Ikizler; Nancy J Brown
Journal:  J Am Soc Nephrol       Date:  2011-12-08       Impact factor: 10.121

4.  Performance and Hemocompatibility of a Novel Polysulfone Dialyzer: A Randomized Controlled Trial.

Authors:  Götz Ehlerding; Ansgar Erlenkötter; Adelheid Gauly; Bettina Griesshaber; James Kennedy; Lena Rauber; Wolfgang Ries; Hans Schmidt-Gürtler; Manuela Stauss-Grabo; Stephan Wagner; Adam M Zawada; Sebastian Zschätzsch; Manuela Kempkes-Koch
Journal:  Kidney360       Date:  2021-04-07

5.  Hemocompatibility of Polysulfone Hemodialyzers - Exploratory Studies on Impact of Treatment Modality and Dialyzer Characteristics.

Authors:  Stephan Wagner; Sebastian Zschätzsch; Ansgar Erlenkoetter; Lena Rauber; Manuela Stauss-Grabo; Adelheid Gauly
Journal:  Kidney360       Date:  2020-01-09

6.  Possible role of new pressor protein in hypertensive anephric hemodialysis patients.

Authors:  Rachel J Pearl; Peter C Papageorgiou; Michael Goldman; Akis A Amfilochiadis; Frans Boomsma; Rasmus Rojkjaer; Denis Geary; Daniel H Osmond
Journal:  Pediatr Nephrol       Date:  2003-08-12       Impact factor: 3.714

Review 7.  Dialysis headache.

Authors:  Ana Luisa de Lima Antoniazzi; Alexandre Pinto Corrado
Journal:  Curr Pain Headache Rep       Date:  2007-08

Review 8.  Complement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pH.

Authors:  Hany Ibrahim Kenawy; Ismet Boral; Alan Bevington
Journal:  Front Immunol       Date:  2015-05-06       Impact factor: 7.561

9.  A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.

Authors:  Brian Spencer; Elvira Valera; Edward Rockenstein; Margarita Trejo-Morales; Anthony Adame; Eliezer Masliah
Journal:  Mol Neurodegener       Date:  2015-09-23       Impact factor: 14.195

10.  Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning--a word of caution.

Authors:  Erik Helgeland; Lars Ertesvåg Breivik; Marc Vaudel; Øyvind Sverre Svendsen; Hilde Garberg; Jan Erik Nordrehaug; Frode Steingrimsen Berven; Anne Kristine Jonassen
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.